Pneumococcal meningitis: An evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae

doi:10.1016/S0163-4453(85)91585-3

Journal of Infection

Volume 10, Issue 2, March 1985, Pages 143-157

https://doi.org/10.1016/S0163-4453(85)91585-3 Get rights and content

Summary

During the period 1966–76, 164 patients with pneumococcal meningitis were admitted to the University Hospital, Copenhagen. Of iii survivors 94 underwent a series of clinical examinations. The findings in each patient were assessed for their aetiological relationship to meningitis. Of these patients 54% had neurological sequelae, 42% had neuropsychological sequelae, 25 % had otological sequelae and 16% had sequelae as judged by computer-assisted tomography of the brain.

On the basis of the general clinical condition, each patient was evaluated for the presence of sequelae of meningitis by means of a rating of nil, mild, moderate or severe. These ratings and mortality rates were used to evaluate the prognostic significance of various features present during the acute illness. A fatal outcome was significantly associated with increasing age, concomitant pneumonia, altered consciousness on admission, transfer from another hospital and development of complications while in hospital. There was a statistically significant association between lasting sequelae and the female sex, the age group of 16–50 years, patients who had not received any pre-admission antibiotic therapy and those with positive bacterial cultures of specimens from sites other than blood or cerebrospinal fluid.

References (14)

BohrV et al.
Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: Clinical data, prognosis, and the role of specialised hospital departments
J Infect
(1983)
BohrV et al.
Sequelae from bacterial meningitis and their relation to the clinical condition during acute illness, based on 667 questionnaire returns. Part II of a three-part series
J Infect
(1983)
BohrV et al.
875 Cases of bacterial meningitis: Diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series
J Infect
(1983)
CarpenterRR et al.
The clinical spectrum of bacterial meningitis
Am J Med
(1962)
NemirRL et al.
Pneumococcic meningitis in infants and children
JAMA
(1951)
AlexanderJD et al.
Pneumococcal meningitis; study of one hundred and two cases
Arch Intern Med
(1953)
WeissW et al.
Prognostic factors in pneumococcal meningitis
Arch Intern Med
(1967)

There are more references available in the full text version of this article.

Cited by (63)

Aquaporins AQP1 and AQP4 in the cerebrospinal fluid of bacterial meningitis patients
2011, Neuroscience Letters
Aquaporins facilitate water transport through cell membranes. Due to the localization of AQP1 and AQP4 in the brain, they might contribute to cerebral edema.
Our study aimed to determine whether AQP1 and AQP4 can be measured in cerebrospinal fluid (CSF), and whether there is a difference in AQP1 and AQP4 concentration between patients with bacterial meningitis (BM) and healthy controls.
AQP1 and AQP4 concentrations in CSF from 35 patients with BM and 27 controls were analyzed using a commercial ELISA.
The mean concentration of AQP1 in CSF was significantly elevated in patients with BM (BM: 3.8 ± 3.4 ng/ml, controls: 0.8 ± 0.5 ng/ml; p < 0.001). AQP4 had a tendency to be increased, however the difference was not significant (BM: 1.8 ± 3.1 ng/ml, controls: 0.1 ± 0.2 ng/ml; p = 0.092). AQP1 and AQP4 in CSF of BM patients were inversely correlated (r = −0.47, p = 0.004). We could not find any other correlation between concentration of AQP1 or AQP4 in CSF and CSF leukocytes, lactate, protein, albumin CSF/serum ratio, age, a prediction score, an outcome score or the Glasgow Coma Scale at admission in patients with BM. Control patients displayed a correlation between AQP1 and the albumin CSF/serum ratio (r = 0.390, p = 0.040).
This is the first study that detected AQP1 and AQP4 in CSF. Whether the significant elevation of AQP1 is due to a higher expression and subsequent shedding into CSF or a BM-induced cell damage needs to be determined.
Cognitive outcome in adults with moderate disability after pneumococcal meningitis
2006, Journal of Infection
To assess cognitive outcome and quality of life in patients with moderate disability after bacterial meningitis as compared to patients with good recovery.
Neuropsychological evaluation was performed in 40 adults after pneumococcal meningitis; 20 patients with moderate disability at discharge on the glasgow outcome scale (GOS score 4) and 20 with good recovery (GOS score 5).
Patients with GOS score 4 had similar test results as compared to patients with GOS score 5 for the neuropsychological domains ‘intelligence’, ‘memory’ and ‘attention and executive functioning’. Patients with GOS score 4 showed less cognitive slowness than patients with GOS score 5. In a linear regression analysis cognitive speed was related to current intelligence, years of education and time since meningitis. Overall performance on the speed composite score correlated significantly with time since meningitis (−0.62; P<0.001). Therefore, difference between both groups may have been related to a longer time between meningitis and testing for GOS four patients (29 vs. 12 months; P<0.001).
Patients with moderate disability after bacterial meningitis are not at higher risk for neuropsychological abnormalities than patients with good recovery. In addition, cognitive slowness after bacterial meningitis may be reversible in time.
Clinical features, complications, and outcome in adults with pneumococcal meningitis: A prospective case series
2006, Lancet Neurology
Citation Excerpt :
Case series on adults with pneumococcal meningitis have been published previously. However, these studies were mainly retrospective.1,3–15 In this prospective cohort study we provide a detailed description of the clinical course, the spectrum of complications, prognostic factors, and outcome in 352 adults with community-acquired pneumococcal meningitis.
Bacterial meningitis is a grave disease of high incidence, especially in less developed countries. Here, we describe its clinical presentation, spectrum of complications, prognostic factors, and outcome in adults with pneumococcal meningitis.
From October, 1998, to April, 2002, we assessed 352 episodes of community-acquired pneumococcal meningitis, confirmed by culture of cerebrospinal fluid (CSF), which occurred in patients older than 16 years. Predictors for an unfavourable outcome (Glasgow outcome scale score 1–4) were identified by logistic regression with multiple imputation techniques.
245 (70%) episodes of pneumococcal meningitis were associated with an underlying disorder. Cranial CT was done for 85% of episodes and revealed underlying disorders in 17% (50/299) and meningitis-associated intracranial complications in 39% (117/299). Independent predictors for an unfavourable outcome were a low score on the Glasgow coma scale, cranial nerve palsies, a raised erythrocyte sedimentation rate, a CSF leucocyte count less than 1000 cells per mm³, and a high CSF protein concentration on admission. Overall in-hospital mortality was 30%. Prevalence of neurological and systemic complications did not differ between patients aged younger than 60 years and those aged 60 years and older; however, systemic complications were the cause of death in 59% (32/54) of fatal episodes in patients aged 60 years and older, whereas neurological complications were the cause of death in 65% (20/31) of fatal episodes in younger patients.
Pneumococcal meningitis is associated with high mortality and morbidity rates in adults. Whereas neurological complications are the leading cause of death in younger patients, elderly patients die predominantly from systemic complications.
Adult Streptococcus pneumoniae meningitis in Southern Taiwan: Epidemiologic trends and prognostic factors
2005, Journal of Clinical Neuroscience
The clinical features of 22 adult patients with Streptococcus pneumoniae meningitis, retrospectively collected over a 16-year period, were reviewed. Otopharyngeal infection, haematogenous spread and cranial neurosurgery continue to be the predominant routes of infection. Most patients acquired the infection in the community, and predisposing underlying conditions are common. The proportion of S. pneumoniae meningitis compared to all microorganisms causing meningitis in adults declined dramatically from 17% in the first 8 study years to 4% in the last 8 study years. However, all penicillin-resistant S. pneumoniae strains were found in the second half of the study period, accounting for 25% of these episodes. The overall mortality rates for the first and second halves of the study period were 43% and 63%, respectively. Third-generation cephalosporins were the antibiotics of choice for the treatment of S. pneumoniae meningitis in this study, however, the emergence of resistant strains may create a therapeutic challenge in the future. To avoid treatment failure, early diagnosis, careful monitoring of the clinical course and the choice of appropriate antibiotics according to the in vitro antimicrobial susceptibilities, are necessary.
Tick-borne encephalitis - Pathogenesis, clinical course and long-term follow-up
2003, Vaccine
The prospective studies available today confirm the experience gained from several retrospective studies that TBE is a disease with a severe acute clinical course and considerable long-term morbidity. A defined post-encephalitic TBE syndrome exists, causing long-lasting morbidity that often affects the quality of life and sometimes also forces the individual to a change in life-style. The sequelae render high costs for individual patients and the society. Three clinical courses may be identified: one with complete recovery within 2 months, occurring in approximately one fourth of patients, one with protracted, mainly cognitive dysfunction, and one with persisting spinal nerve paralysis with or without other post-encephalitic symptoms. Up to 46% of patients are left with permanent sequelae at long-time follow-up, the most commonly reported residuals being various cognitive or neuropsychiatric complaints, balance disorders, headache, dysphasia, hearing defects, and spinal paralysis. This knowledge enhances the need for continued local epidemiological surveillance of TBE to form a basis for vaccination policies. Even though knowledge of the clinical course of TBE has improved in recent years, there are still several aspects of this disease that warrant further studies. These comprise the clinical picture and prognosis in children, an evaluation of different rehabilitation strategies, and an improved understanding of pathogenic mechanisms to permit the development of antiviral or, maybe more probable, immune modulatory treatment strategies.
Addition of daptomycin for the treatment of pneumococcal meningitis: Protocol for the AddaMAP study
2023, BMJ Open

View all citing articles on Scopus

View full text

Original articlePneumococcal meningitis: An evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae

Summary

J Infect

J Infect

J Infect

Am J Med

Pneumococcic meningitis in infants and children

JAMA

Pneumococcal meningitis; study of one hundred and two cases

Arch Intern Med

Prognostic factors in pneumococcal meningitis

Arch Intern Med

Original article
Pneumococcal meningitis: An evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae